Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Endometriosis Pain
NCT04527003Phase 3Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Dec 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cannabidiol in endometriosis (3 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Pain Score Area Under the Curve at 8 weeks. Started Dec 2020; status: terminated.
02
Drugs
cannabidiol
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04527003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04527003.